Skip to main content

Advertisement

SpringerLink
Log in

Medication use in the treatment of migraine during pregnancy and lactation

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Migraine is very common in women of reproductive age. With peak prevalence of migraine occurring during childbearing years, many women with migraine may knowingly or unknowingly use medication during pregnancy. Although migraine tends to improve during pregnancy, many women may still experience moderate to severe disabling headache and need pharmacologic treatment for the pain, nausea, and vomiting. This article explores the physiologic changes occurring during pregnancy that can affect pharmacokinetic properties of drugs and their metabolism. Acute and preventive treatment of migraine during pregnancy and lactation is discussed, with an emphasis on safety to the fetus and nursing infant. Safety and recommended use of medication during pregnancy may be different when use is considered during breastfeeding. A goal of treatment is to balance potential risk of treatment to the fetus and nursing infant with significant relief and return to normal function of the mother.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Lipton RB, Bigal ME: The epidemiology of migraine. Am J Med 2005, 118(Suppl 1):3S–10S.

    PubMed  Google Scholar 

  2. Marcus DA: Managing headache during pregnancy and lactation. Exp Rev Neurother 2008, 8:385–395.

    Article  Google Scholar 

  3. Sances G, Granella F, Nappi R, et al.: Course of migraine during pregnancy and postpartum: a prospective study. Cephalalgia 2003, 23:197–205.

    Article  PubMed  CAS  Google Scholar 

  4. Melhado EM, Maciel JA, Guerreiro CM: Headache during gestation: evaluation of 1101 women. Can J Neurol Sci 2007, 34:187–192.

    PubMed  Google Scholar 

  5. Pregnancy categories for prescription drugs. FDA Drug Bulletin 1982, 12:24–25.

  6. Boothby LA, Doering PL: FDA labeling systems for drugs in pregnancy. Ann Pharmacother 2001, 35:1485–1489.

    Article  PubMed  CAS  Google Scholar 

  7. Koren G, Pastuszak A, Ho S: Drugs in pregnancy. N Engl J Med 1998, 338:1128–1137.

    Article  PubMed  CAS  Google Scholar 

  8. Anderson G. Using pharmacokinetics to predict effects of pregnancy and maternal-infant transfer of drug during lactation. Exp Opin Drg Metab Toxicol 2006, 2:947–960.

    Article  CAS  Google Scholar 

  9. Soldin OP, Dahlin J, O’Mara DM: Triptans in pregnancy. Ther Drug Monit 2008, 30:5–9.

    Article  PubMed  CAS  Google Scholar 

  10. Evans EW, Lorbe KC: Use of 5-HT agonists in pregnancy. Ann Pharmacother 2008, 42:543–549.

    Article  PubMed  CAS  Google Scholar 

  11. Loder E: Safety of sumatriptan in pregnancy: a review of the literature so far. CNS Drugs 2003, 17:1–7.

    Article  PubMed  CAS  Google Scholar 

  12. O’Quinn S, Ephross SA, Williams V, et al.: Pregnancy and perinatal outcomes in migraineurs using sumatriptan: a prospective study. Arch Gynecol Obstet 1999, 263:7–12.

    Article  PubMed  Google Scholar 

  13. Shuhaiber S, Pastuszak A, Schick B, et al.: Pregnancy outcome following first trimester exposure to sumatriptan. Neurology 1998, 51:581–583.

    PubMed  CAS  Google Scholar 

  14. Schenker S, Yang Y, Perez A, et al.: Sumatriptan (Imitrex) transport by the human placenta. Proc Soc Exp Biol Med 1995, 210:213–220.

    PubMed  CAS  Google Scholar 

  15. Guputa S, Hanff LM, Visser W, et al.: Functional reactivity of 5-HT receptors in human umbilical cord and maternal subcutaneous fat arteries after normotensive or pre-eclamptic pregnancy. J Hypertens 2006, 24:1345–1353.

    Article  CAS  Google Scholar 

  16. GlaxoSmithKline: Sumatriptan and naratriptan pregnancy registry interim report (January 1996 through October 31, 2008). Available at http://pregnancyregistry.gsk.com/documents/sum-nar_interim_report_2009.pdf.

  17. Li DK, Liu L, Odouli R: Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. Br Med J 2003, 327:368.

    Article  CAS  Google Scholar 

  18. Silberstein SD for the US Headache Consortium: American Academy of Neurology practice parameter: evidence-based guidelines for migraine headache (an evidence based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology 2000, 538–547.

  19. Einarson A, Maltepe C, Narioz Y, et al.: The safety of ondansetron for nausea and vomiting of pregnancy: a prospective comparative study. BJOG 2004, 111:940–943.

    Article  PubMed  CAS  Google Scholar 

  20. Physicians’ Desk Reference: Ondansetron. New York, NY: Thomson Reuters; 2009.

  21. Karlsson C, Bodelsson G, Bodelsson M, et al.: Characterization of 5-hydroxytrypamine receptors mediating circular smooth muscle contraction in the human umbilical artery. Gynecol Obstet Invest 1999, 47:102–107.

    Article  PubMed  CAS  Google Scholar 

  22. Bsat F, Hoiffman DE, Seubert DE: Comparison of three outpatient regimens in the management of nausea and vomiting in pregnancy. J Perinatol 2003, 23:531–535.

    Article  PubMed  CAS  Google Scholar 

  23. Gur C, Diav-Citrin O, Shectman S, et al.: Pregnancy outcome after first trimester exposure to corticosteroids: a prospective controlled study. Reprod Toxicol 2004, 18:93–101.

    Article  PubMed  CAS  Google Scholar 

  24. Pfaffenrath V, Rehm M: Migraine in pregnancy: what are the safest treatment options? Drug Saf 1998, 19:383–388.

    Article  PubMed  CAS  Google Scholar 

  25. Marcus DA: Pregnancy and chronic headache. Expert Opin Pharmacother 2002, 3:389–393.

    Article  PubMed  CAS  Google Scholar 

  26. Wall VR: Breastfeeding and migraine headaches. J Hum Lact 1992, 8:209–212.

    Article  PubMed  CAS  Google Scholar 

  27. Begg, EJ, Duffull SB, Hackett LP, et al.: Studying drugs in human milk: time to unify the approach. J Hum Lact 2002, 18:323–332.

    Article  PubMed  Google Scholar 

  28. Larsen LA, Ito S, Koren G: Prediction of milk/plasma concentration ratio of drugs. Ann Pharmacother 2003, 37:1299–1300.

    Article  PubMed  CAS  Google Scholar 

  29. Atkinson HC, Begg EJ: Prediction of drug distribution into human milk from physicochemical characteristics. Clin Pharmacokinet 1990, 18:151–167.

    Article  PubMed  CAS  Google Scholar 

  30. Riant P, Urien S, Albengres E, et al.: High plasma protein binding as a parameter in the selection of betablockers for lactating women. Biochem Pharmacol 1986, 35:4579–4581.

    Article  PubMed  CAS  Google Scholar 

  31. Sumatriptan [package insert]. Research Triangle Park, NC: GlaxoSmithKline; 2007.

  32. Eletriptan [package insert]. New York, NY: Pfizer; 2007.

  33. Wojnar-Harton RE, Hackett LP, Yapp P, et al.: Distribution and excretion of sumatriptan in human milk. Br J Clin Pharmacol 1996, 41:217–221.

    Article  Google Scholar 

  34. American Academy of Pediatrics Committee on Drugs: Transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776–789.

    Google Scholar 

  35. American Academy of Pediatrics: Policy statements. Available at http://aappolicy.aappublications.org/cgi/reprint/pediatrics.

  36. Hale TW: Medications and Mothers’ Milk. Amarillo, TX: Hale Publishing; 2008.

    Google Scholar 

  37. Weibert RI, Townsend RJ, Kaiser DG, et al.: Lack of ibuprofen secretion into human milk. Clin Pharm 1982, 1:457–458.

    PubMed  CAS  Google Scholar 

  38. Townsend RJ, Benedetti TJ, Erickson SH, et al.: Excretion of ibuprofen into breast milk. Am J Obstet Gynecol 1984, 149:184–186.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The Headache Center, University of Washington Medical Center, 1959 NE Pacific Street, Box 356097, Seattle, WA, 98195, USA

    Sylvia Lucas

Authors
  1. Sylvia Lucas
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sylvia Lucas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lucas, S. Medication use in the treatment of migraine during pregnancy and lactation. Current Science Inc 13, 392–398 (2009). https://doi.org/10.1007/s11916-009-0064-3

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-009-0064-3

Keywords

Search

Navigation